KOMPARASI PENJUALAN OBAT PREKURSOR SEBELUM DAN SESUDAH INSPEKSI BPOM DI APOTEK KIMIA FARMA 61 VETERAN BANJARMASIN TAHUN 2017

  • Noor Aisyah Akademi Farmasi ISFI Banjarmasin
  • Desi Rahmida Akademi Farmasi ISFI Banjarmasin
  • Mochammad Maulidie Alfiannor Saputera Akademi Farmasi ISFI Banjarmasin
  • Shela Puzi Dina Akademi Farmasi ISFI Banjarmasin
Keywords: sales, precursor drugs, pseudoephedrine

Abstract

Submission of pharmaceutical drug precursors for hard drugs to patients must be prescribed by a doctor. The use of inappropriate precursors can be misused for the manufacture of illegal narcotics and psychotropics, including Pseudoephedrine. The purpose of this study was to determine the comparison of the sales of pseudoephedrine precursor drugs, hard drug groups that used prescriptions and did not use prescriptions before and after the inspection of the BPOM. This research was conducted at Kimia Farma Pharmacy No. 61 Veteran Banjarmasin with descriptive method. The population taken in the study was the sale of precursor drugs containing pseudoephedrine hard drug, three months before and three months after the BPOM inspection. The samples in this study were data on drug sales in the KIS system, the drugs were Aldisa sr sr, Lapifed, SR Rhinos, Rhinofed, Trifed and Tremenza. Data analysis was the Mann Whitney U-test. The results showed that there was no difference in sales of hard drug precursor of the pseudoephedrine type using prescription before and after BPOM inspection based on the Mann Whitney U-test with a significance value of0.579(p>0.05), and there were differences in the drug sales that did not use prescription with a significance value of0,000(p <0.05).

References

Kepala Badan Pengawasan Obat dan Makanan Republik Indonesia., 2013, Peraturan Kepala Badan Pengawasan Obat dan Makanan Republik Indonesia Nomor 40 Tentang Pedoman Pengelolaan Prekursor Farmasi dan Obat Mengandung Pekursor Farmasi, Jakarta, Kepala Badan Pengawasan Obat dan Makanan Republik Indonesia.

Kementerian Kesehatan Republik Indonesia., 2015, Peraturan Menteri Kesehatan RI Nomor 3 Tentang Peredaran, Penyimpanan, Pemusnahan, dan Pelaporan Narkotika, Psikotropika, dan Prekursor Farmasi. Jakarta, Kementrian Kesehatan Republik Indonesia.

Usman. D. S. A., Kadir. W. S., Moo D.R., 2015, Studi Pengelolaan Obat yang Mengandung Prekursor pada Apotek di Kabupaten Buol, Fakultas Farmasi, Program Studi S1, Jurusan Farmasi, FIKK, UNG.

Hamzah.A. A. A., 2014., Pemidanaan Terhadap Penyalahgunaan Prekursor di Kalangan Korporasi, Jurnal Lex Crimen, Volume III (2), April 2014 https://ejournal.unsrat.ac.id/index.php/lexcrimen/article/view/4540

Suriangka. A., 2017., Perlindungan Konsumen Terhadap Penyaluran Obat Keras Daftar G Oleh Badan POM di Makasar, Jurnal Jurisprudentie, Volume 4 (2) Desember2017, http://journal.uin-alauddin.ac.id/index.php/Jurisprudentie/article/view/4044

Dahlan, M.S., 2015. Statistika Untuk Kedokteran dan Kesehatan, Edisi 6, Epidemiologi Indonesia, Jakarta, Indonesia.

Published
2019-05-29
How to Cite
1.
Aisyah N, Rahmida D, Saputera M, Dina S. KOMPARASI PENJUALAN OBAT PREKURSOR SEBELUM DAN SESUDAH INSPEKSI BPOM DI APOTEK KIMIA FARMA 61 VETERAN BANJARMASIN TAHUN 2017. JIFI [Internet]. 29May2019 [cited 18Jun.2019];2(1):89-7. Available from: http://jiis.akfar-isfibjm.ac.id/index.php?journal=JIFI&page=article&op=view&path[]=319
Section
Articles